In breast cancer cells, estradiol activates the SRC/RAS/ERK kinase pathway via a small fraction of the nuclear estrogen receptor alpha (ERα) attached to the cell membrane (mbERα) [5]. The gene discussed is ESR1; the disease is breast carcinoma.